Organization | Entebbe General Hospital

Entebbe General Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2017

NCT03412071

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2017

Timeline

NOW

Now

Alternative names

Entebbe General Hospital

Active Ingredients

Drugs in Other Trials (4)

clindamycin (cleocin) (1 trial)

hydrogen peroxide (1 trial)

metronidazole (flagyl) (1 trial)

tinidazole (tindamax) (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 1
# of Trial APIs: 4